[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356710-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356710-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ilf3-regulates-cell-proliferation-and-metastasis-by-competitively-antagonizing-the-interaction-between-hmgcl-and-usp38-in-hepatocellular-carcinoma","ILF3 Regulates Cell Proliferation and Metastasis by Competitively Antagonizing the Interaction Between HMGCL and USP38 in Hepatocellular Carcinoma","","Hepatocellular carcinoma (HCC) is a major primary liver cancer, and interleukin enhancer–binding factor 3 (ILF3) has been linked to multiple cancers. This study tests how ILF3 drives HCC progression by regulating ILF3-dependent molecular events. ILF3 levels were assessed by IHC and Western blot, with functional effects evaluated via in vitro assays and in vivo models. Co-immunoprecipitation identified HMGCL as an ILF3-binding partner, and protein stability, ubiquitination, and pathway analyses were used to define the mechanism. ILF3 promotes proliferation and metastasis by disrupting USP38-mediated deubiquitination of HMGCL, enhancing HMGCL ubiquitination and degradation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ilf3-regulates-cell-proliferation-and-metastasis-by-competitively-antagonizing-the-interaction-between-hmgcl-and-usp38-in-hepatocellular-carcinoma/356710/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ilf3-regulates-cell-proliferation-and-metastasis-by-competitively-antagonizing-the-interaction-between-hmgcl-and-usp38-in-hepatocellular-carcinoma/356710.png","ImageObject",300,407,{"name":42,"@type":43},"Angel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How did the study evaluate ILF3 expression in hepatocellular carcinoma?","Question",{"text":63,"@type":64},"ILF3 expression was determined using immunohistochemistry (IHC) and Western blot (WB) analyses.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does ILF3 play in HCC progression according to the findings?",{"text":68,"@type":64},"ILF3 was significantly upregulated in HCC, and patients with high ILF3 expression showed poor prognosis; ILF3 knockdown inhibited HCC cell proliferation and metastasis in vitro and in vivo.",{"name":70,"@type":61,"acceptedAnswer":71},"How does ILF3 regulate HMGCL stability and tumor behaviors?",{"text":72,"@type":64},"ILF3 binds HMGCL and accelerates its protein degradation; it also disrupts the interaction between USP38 and HMGCL, enhancing HMGCL ubiquitination and degradation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356710,1790592101,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Human Mutation  \n SPECIAL ISSUE  Variant-to-Biomarker: Multi-omics Integration for Interpreting Human Genetic Variation and Clinical Translation  \nRESEARCH ARTICLE  OPEN ACCESS   \nILF3 Regulates Cell Proliferation and Metastasis by Competitively Antagonizing the Interaction Between HMGCL and USP38 in Hepatocellular Carcinoma  \nQingqing Luo1, 2 | Lei Xiao3 | Ganlu Deng4 | Tan Deng2 | Wenchao Zhao2 | Rensheng Wang1 | Xueying Hu1  \n1Department of Radiation Oncology & Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China | 2Department of Oncology, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan Province, China | 3Department of Colorectal Surgery, Hunan Cancer Hospital/Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan Province, China | 4Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China  \nCorrespondence: Rensheng Wang ([13807806008@163.com](13807806008@163.com)) | Xueying Hu ([huxueying1987@sr.gxmu.edu.cn](huxueying1987@sr.gxmu.edu.cn))  \nReceived: 6 January 2026 | Revised: 1 March 2026 | Accepted: 31 March 2026  \nGuest Editor: Hao Chi  \nKeywords: deubiquitinase | HCC | HMGCL | ILF3 | USP38  \nABSTRACT  \nBackground: Hepatocellular carcinoma (HCC) is a major type of primary liver cancer. Previous studies have reported that interleukin enhancer–binding factor 3 (ILF3) is involved in the regulation of multiple cancers. This study investigated the molecular mechanisms whereby ILF3 promotes HCC progression.  \nMethods: ILF3 expression levels were determined through immunohistochemistry (IHC) and Western blot (WB) analyses. The biological functions ofILF3 in HCC were evaluated using both in vitro assays and in vivo animal models. Co-immunoprecipitation (Co-IP) was carried out to identify HMGCL as a binding partner ofILF3. To clarify the potential molecular pathways underlying ILF3-mediated regulation of HCC malignant behaviors, protein stability assays and in vitro ubiquitination experiments were performed.  \nResults: ILF3 was significantly upregulated in HCC. The patients with high expression of ILF3 showed poor prognosis in our cohort. ILF3 knockdown inhibited the proliferation and metastasis of HCC cells both in vitro and in vivo in this study. Mechanistically, ILF3 was found to be bound to HMGCL and to accelerate its protein degradation. Additionally, we found that ILF3 promotes HCC cell proliferation and metastasis through HMGCL. Overexpression of HMGCL in ILF3-upregulated HCC cells could significantly reverse the proliferation and invasion role of ILF3 on HCC cells. Moreover, USP38 was identified as adeubiquitinating enzyme that participates in promoting the stability of HMGCL. ILF3 disrupted the interaction between USP38 and HMGCL, thereby enhancing HMGCL ubiquitination and accelerating its degradation.  \nConclusion: ILF3 promotes the proliferation and metastasis of HCC by enhancing the ubiquitination ofHMGCL by interfering with the interaction between the deubiquitinase USP38 and HMGCL.  \n1 | Introduction  \nHepatocellular carcinoma (HCC) accounts for a predominant subtype of primary liver cancer, frequently linked to chronic  \nliver disease and cirrhosis [1, 2] . HCC also serves as one of the top contributors to cancer-related mortality in the world. There are approximately 830,000 new patients diagnosed with HCC each year [3–6] . In current clinical practice, molecularly  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nCopyright © 2026 Qingqing Luo et al. Human Mutation published by John Wiley & Sons Ltd.  \nHuman Mutation, 2026; 2026:2654435 1 of 13  \n[https://doi.org/10.1155/humu/2654435](http","cbCaikbqt3Nm9rZX","https://ap.wps.com/l/cbCaikbqt3Nm9rZX","pdf",16117146,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"How did the study evaluate ILF3 expression in hepatocellular carcinoma?\",\"answer\":\"ILF3 expression was determined using immunohistochemistry (IHC) and Western blot (WB) analyses.\"},{\"question\":\"What role does ILF3 play in HCC progression according to the findings?\",\"answer\":\"ILF3 was significantly upregulated in HCC, and patients with high ILF3 expression showed poor prognosis; ILF3 knockdown inhibited HCC cell proliferation and metastasis in vitro and in vivo.\"},{\"question\":\"How does ILF3 regulate HMGCL stability and tumor behaviors?\",\"answer\":\"ILF3 binds HMGCL and accelerates its protein degradation; it also disrupts the interaction between USP38 and HMGCL, enhancing HMGCL ubiquitination and degradation.\"}]","ILF3 Regulates Cell Proliferation and Metastasis by Competitively Antagonizing the Interaction Between HMGCL and USP38 in Hepatocellular Carcinoma | PDF",1790126891,33,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/865872202668f1ee92d1413b7f1548fa.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f52f3c5295f9dd10dbc330c37597afb9.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/177f325b8e3f36122cd9245a65fffbe8.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b8825b9cc37677846734a5b1a7eccc8.webp",980,1287]